The goal of this project is to improve transvascular transport in solid tumors. This will involve quantification of various physiological, morphological and molecular pathways in vascular transport. We plan to measure permeability and permeability related factors, hydraulic conductivity and microvascular pressures, and endothelial pore-sizes, involved in these transport mechanisms. These goals will be accomplished by using various different but complementary techniques: i) a highly specialized in vivo technique that allows quantification of transport parameters in individual tumor microvessels, i.e. permeability (P) and hydraulic conductivity (Lp), ii) macromolecules of increasing size to quantify pore-sizes, iii) immunohistology to localize Vascular Permeability Factor, also known as Vascular Endothelial Growth Factor (VPF/VEGF) and its receptors flt-1 and flk (or kdr), iv) in situ hybridization to quantify mRNA expression of VPF and its cognate receptors in vascular endothelial cells and v) northern blotting to quantify the total amount of VPF present in tumors. Combination of the results of these techniques will greatly enhance our understanding of transvascular transport in individual tumor vessels and allow us to improve the delivery of therapeutic molecules in solid tumors. The proposed project represents the first detailed and comprehensive investigation of molecular transport at the level of individual vessels in tumors.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32CA072214-02
Application #
2668053
Study Section
Radiation Study Section (RAD)
Program Officer
Lohrey, Nancy
Project Start
1998-02-15
Project End
Budget Start
1998-02-15
Budget End
1999-02-14
Support Year
2
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Lichtenbeld, H C; Ferarra, N; Jain, R K et al. (1999) Effect of local anti-VEGF antibody treatment on tumor microvessel permeability. Microvasc Res 57:357-62